Published in Biochemistry on August 31, 1993
Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv Immunol (2014) 1.38
Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infect Immun (1998) 1.32
The therapeutic potential of interleukin-10 in neuroimmune diseases. Neuropharmacology (2014) 0.98
Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol (2013) 0.92
Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus. PLoS One (2011) 0.83
Structural mapping of post-translational modifications in human interleukin-24: role of N-linked glycosylation and disulfide bonds in secretion and activity. J Biol Chem (2009) 0.82
Improving health from the inside: Use of engineered intestinal microorganisms as in situ cytokine delivery system. Bioengineered (2012) 0.81
Rational Structure-Based Rescaffolding Approach to De Novo Design of Interleukin 10 (IL-10) Receptor-1 Mimetics. PLoS One (2016) 0.76
A network map of Interleukin-10 signaling pathway. J Cell Commun Signal (2015) 0.76
Cloning of interleukin-10 from African clawed frog (Xenopus tropicalis), with the Finding of IL-19/20 homologue in the IL-10 locus. J Immunol Res (2015) 0.76
Structural and Functional Characterization of Recombinant Interleukin-10 from Indian Major Carp Labeo rohita. J Immunol Res (2016) 0.75
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
X-ray structure determination of fully hydrated L alpha phase dipalmitoylphosphatidylcholine bilayers. Biophys J (1996) 5.60
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med (1996) 5.38
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest (2000) 4.36
Survival by time of day of hemodialysis in an elderly cohort. JAMA (2001) 4.09
Measurement of chain tilt angle in fully hydrated bilayers of gel phase lecithins. Biophys J (1993) 4.08
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology (2001) 3.25
The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23
Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature (1994) 3.19
Relationship of a putative receptor protein kinase from maize to the S-locus glycoproteins of Brassica. Nature (1990) 3.11
The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev (1992) 2.69
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68
Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators. J Med Chem (1995) 2.68
Synthetic nano-scale fibrous extracellular matrix. J Biomed Mater Res (1999) 2.21
Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med (1991) 2.16
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A (2001) 1.92
Atomic resolution imaging of a carbon nanotube from diffraction intensities. Science (2003) 1.90
Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat Struct Biol (2000) 1.89
Three-dimensional structure of recombinant human interferon-gamma. Science (1991) 1.88
Cytokinin Biochemistry in Relation to Leaf Senescence: IV. Cytokinin Metabolism in Soybean Explants. Plant Physiol (1988) 1.87
Lung cancer among Chinese women. Int J Cancer (1987) 1.83
Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia (2009) 1.83
Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth. J Cell Biol (1990) 1.82
Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol (1996) 1.75
Analysis of distribution of bases in the coding sequences by a diagrammatic technique. Nucleic Acids Res (1991) 1.75
A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function. J Bacteriol (1999) 1.65
Remote oxidation of steroids by photolysis of attached benzophenone groups. J Am Chem Soc (1973) 1.58
Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein. J Virol (1996) 1.56
Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res (2001) 1.55
Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. Circ Res (1999) 1.54
Perspectives on the new kidney disease education benefit: early awareness, race and kidney transplant access in a USRDS study. Am J Transplant (2012) 1.51
Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem (2000) 1.51
Comparison of the free and DNA-complexed forms of the DNA-binding domain from c-Myb. Nat Struct Biol (1995) 1.46
Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue. Biochemistry (1998) 1.46
Continuous positive airway pressure: patients' and caregivers' learning needs and barriers to use. Heart Lung (1998) 1.43
Application of analytical and preparative high-speed counter-current chromatography for separation of alkaloids from Coptis chinensis Franch. J Chromatogr A (1998) 1.42
ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem (2000) 1.42
A picoliter-volume mixer for microfluidic analytical systems. Anal Chem (2001) 1.38
Microtubular architecture of biodegradable polymer scaffolds. J Biomed Mater Res (2001) 1.38
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer (2005) 1.36
IFN inhibits inflammatory responses and protective immunity in mice infected with the nematode parasite, Nippostrongylus brasiliensis. J Immunol (1993) 1.36
Glutamine-binding subunit of glutamate synthase and partial reactions catalyzed by this glutamine amidotransferase. Proc Natl Acad Sci U S A (1974) 1.36
Reversible dissociation of carbamyl phosphate synthetase into a regulated synthesis subunit and a subunit required for glutamine utilization. Proc Natl Acad Sci U S A (1971) 1.35
Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc Natl Acad Sci U S A (1997) 1.35
Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res (1996) 1.34
Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev (2001) 1.33
Reversible dissociation of the monomer of glutamine-dependent carbamyl phosphate synthetase into catalytically active heavy and light subunits. J Biol Chem (1974) 1.32
Prospective study of post-traumatic stress disorder in children involved in road traffic accidents. BMJ (1998) 1.32
Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res (1996) 1.31
The status of evidence and outcomes in Stages of Change research. Health Educ Res (2000) 1.31
Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc Natl Acad Sci U S A (1998) 1.30
The crystal structure of a high oxygen affinity species of haemoglobin (bar-headed goose haemoglobin in the oxy form). J Mol Biol (1996) 1.30
A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiot (Tokyo) (1988) 1.28
Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex. Bioorg Med Chem (1997) 1.27
Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure (1996) 1.26
Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation. Proc Natl Acad Sci U S A (2000) 1.25
Tissue-specific expression of mRNA encoding rat kidney water channel CHIP28k by in situ hybridization. Am J Physiol (1993) 1.24
Evidence for a polypeptide segment at the carboxyl terminus of recombinant human gamma interferon involved in expression of biological activity. Biochemistry (1988) 1.24
Active site-directed inhibitors of Rhodococcus 20 S proteasome. Kinetics and mechanism. J Biol Chem (1997) 1.23
Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites. Antivir Chem Chemother (1999) 1.23
White matter integrity in physically fit older adults. Neuroimage (2013) 1.23
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy. Clin Cancer Res (1998) 1.21
Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic mechanism. Biochemistry (1999) 1.21
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer (2008) 1.21
Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am (2000) 1.21
Ca(2+) channel modulation by recombinant auxiliary beta subunits expressed in young adult heart cells. Circ Res (2000) 1.20
Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population. Diabetologia (2009) 1.20
Improving promoter prediction for the NNPP2.2 algorithm: a case study using Escherichia coli DNA sequences. Bioinformatics (2004) 1.19
Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets. Drug Dev Ind Pharm (2000) 1.19
A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood (1991) 1.17
Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy. Clin Pharmacol Ther (1995) 1.17
A novel method to calculate the G+C content of genomic DNA sequences. J Biomol Struct Dyn (2001) 1.17
Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. J Virol (1997) 1.17
Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats. World J Gastroenterol (2001) 1.15
hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas. Oncogene (2011) 1.14
Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J Biol Chem (1997) 1.14
Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. Public Health (2005) 1.14
An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis. Cell Death Differ (2009) 1.14
Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett (1997) 1.13
Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol (1997) 1.13
A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population. Diabetologia (2008) 1.13
Comparative phylogeography of five avian species: implications for Pleistocene evolutionary history in the Qinghai-Tibetan plateau. Mol Ecol (2009) 1.13
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord (2006) 1.12
Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Clin Cancer Res (2001) 1.12
An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Ther (2002) 1.11
Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J Pathol (2008) 1.11
Our experience on management of Boerhaave's syndrome with late presentation. Dis Esophagus (2008) 1.11
Crystal structure of recombinant human interleukin-4. J Biol Chem (1992) 1.10
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Modeling of nonlinear physiological systems with fast and slow dynamics. II. Application to cerebral autoregulation. Ann Biomed Eng (2002) 1.10
Differential screening of gene expression difference enriched by differential display. Nucleic Acids Res (1996) 1.10
Inhibition by dithiothreitol of the utilization of glutamine by carbamyl phosphate synthetase. Evidence for formation of hydrogen peroxide. J Biol Chem (1974) 1.09